跳至主要内容
临床试验/PACTR201804003255157
PACTR201804003255157已完成未知

Aggressive Antipyrectics in CNS Malaria: A Randomized-Controlled Trial Assessing Antipyretic Efficacy and Parasite Clearance Effects

niversity of Rochester0 个研究点目标入组 284 人开始时间: 2018年3月27日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
284

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 Year(s) 至 11 Year(s)(—)
性别
All

入选标准

  • 1. Evidence of P. falciparum malaria infection by peripheral blood smear or rapid diagnostic test.
  • 2. CNS symptoms associated with malaria. Cerebral malaria: Impaired consciousness with a Blantyre Coma Score (BCS)(73)less than or equal to 2 in children under 5 yrs or a Glasgow Coma Score (GCS)less than or equal to 10 in children greater than or equal to 5 yrs OR CNS MALARIA: Complicated seizure(s), meaning prolonged (>15 minutes), focal or multiple; or impaired consciousness or other evidence of impaired consciousness (confusion, delirium) without frank coma (BCS>2,GCS=11-14).

排除标准

  • 1. Circulatory failure (cold extremities, capillary refill > 3 seconds, sunken eyes, decreased skin turgor).
  • 2. Vomiting in the past 2 hrs.
  • 3. Serum Cr> 1.2 mg/dL.
  • 4. A hx of liver disease.
  • 5. Jaundice or a total bilirubin of >3.0mg/dL.
  • 6. A hx of gastric ulcers or gastrointestinal bleeding.
  • 7. A hx of thrombocytopenia or other primary hematologic disorder.
  • 8. Petechiae or other clinical indications of bleeding abnormalities.
  • 9. A known allergy to ibuprofen, acetaminophen, aspirin or any non-steroidal medication.
  • 10. Any contraindication for nasogastric tube (NGT) placement and/or delivery of enteral medications.

研究者

发起方
niversity of Rochester

相似试验